Mixed connective tissue disease: Difference between revisions

Jump to navigation Jump to search
WikiBot (talk | contribs)
m Robot: Automated text replacement (-{{WikiDoc Cardiology Network Infobox}} +, -<references /> +{{reflist|2}}, -{{reflist}} +{{reflist|2}})
Shankar Kumar (talk | contribs)
No edit summary
Line 1: Line 1:
__NOTOC__
{{SI}}
{{SI}}
{{CMG}}; '''Associate Editor:''' {{CZ}}


 
{{SK}} MCTD; Mixed connective tissue disorder; Sharp's syndrome
==Overview==
==Overview==
'''Mixed connective tissue disease''' ('''MCTD''') or ''Sharp's syndrome'' is a human [[autoimmune disease]] in which the [[immune system]] attacks the body. MCTD combines features of [[polymyositis]], [[systemic lupus erythematosus]], and [[systemic scleroderma]] and is thus considered an [[overlap syndrome]]. MCTD commonly causes [[arthritis|joint pain/swelling]], [[Raynaud phenomenon]], [[myositis|muscle inflammation]], and [[sclerodactyly|scarring of the skin of the hand]]. It does not typically cause [[kidney]] disease or [[seizure]]s. Distinguishing laboratory characteristics are a positive, speckled [[anti-nuclear antibody]] and an [[anti-U1-RNP antibody]].<ref>Venables PJ. ''Mixed connective tissue disease.'' Lupus. 2006;15(3):132-7. PMID 1663436</ref>   
'''Mixed connective tissue disease''' ('''MCTD''') or ''Sharp's syndrome'' is a human [[autoimmune disease]] in which the [[immune system]] attacks the body. MCTD combines features of [[polymyositis]], [[systemic lupus erythematosus]], and [[systemic scleroderma]] and is thus considered an [[overlap syndrome]]. MCTD commonly causes [[arthritis|joint pain/swelling]], [[Raynaud phenomenon]], [[myositis|muscle inflammation]], and [[sclerodactyly|scarring of the skin of the hand]]. It does not typically cause [[kidney]] disease or [[seizure]]s. Distinguishing laboratory characteristics are a positive, speckled [[anti-nuclear antibody]] and an [[anti-U1-RNP antibody]].<ref>Venables PJ. ''Mixed connective tissue disease.'' Lupus. 2006;15(3):132-7. PMID 1663436</ref>   
==Pathophysiology==
There are no specific histologic findings that aid in the diagnosis of [[Mixed Connective Tissue Disorder]] as a separate autoimmune disease. For example, [[nephritis]] in [[MCTD]] is usually indistinguishable from [[lupus]] nephritis.
<div align="left">
<gallery heights="225" widths="225">
image:Fibrous Pericarditis in MCTD.jpg|Fibrous Pericarditis in MCTD
image:Cellular aggregates in perivascular space and adjacent myocardium.jpg|Cellular aggregates in perivascular space and adjacent myocardium
image:Cross Section of Intramural Coronary Artery.jpg|Cross Section of Intramural Coronary Artery
image:Small pulmonary artery in patient with MCTD and pulmonary hypertension.jpg|Small pulmonary artery in patient with MCTD and pulmnonary hypertension
</gallery>
</div>
==Diagnosis==
*[[Raynaud’s phenomenon]]
*Swollen fingers or hands
===Anti–U1 small nuclear RNP positive===
===Mixed Connective Tissue Disorder Findings===
A.[[Systemic lupus erythematosus]]–like findings
*[[Polyarthritis]]
*[[Lymphadenopathy]]
*Facial [[erythema]]
*[[Pericarditis]] or [[pleuritis]]
*[[Leukopenia]] (<4,000/mm3) or thrombocytopenia (<100,000/mm3)
B.[[Scleroderma|Progressive Systemic Sclerosis]] –like findings
*[[Sclerodactyly]]
*[[Pulmonary fibrosis]], restrictive changes of the lung (forced vital capacity <80% of predicted), or reduced carbon monoxide diffusing capacity (<70% of predicted)
*Hypomotility or dilatation of esophagus
C.[[Polymyositis]]-like findings
*Muscle weakness
*Elevated serum level of muscle enzymes (creatine kinase)
*Myogenic pattern on electromyogram
MCTD is characterized by anti–U1 small nuclear RNP positivity.
===Cardiac Involvement in MCTD===
Cardiovascular abnormalities associated with mixed connective tissue disease are rare. Presence of any of the complications listed below indicates unfavorable prognosis;
*Acute [[pericarditis]] and/or [[pericardial effusion]],
*[[Mitral valve prolapse]],
*Intimal hyperplasia of coronary arteries,
*Perivascular and myocardial leukocytic infiltrates,
*[[Pulmonary hypertension]].
*Coronary Artery Disease (although it is rarer, ACS may occur secondary to vascular changes and underlying CAD. The youngest patient with MCTD and ACS in literature was 18 years old)<ref>Jang J J, Olin J W, Fuster V. A teenager with mixed connective tissue disease presenting with an acute coronary syndrome. Vascular Medicine; 2004, Vol. 9 Issue 1, 31-34</ref>
<div align="left">
<gallery heights="225" widths="225">
image:Teenager before PCI.jpg|A teenager with MCTD presented as ACS before PCI
image:Teenager post PCI.jpg|A teenager with MCTD presented as ACS post PCI
</gallery>
</div>


== References ==
== References ==
{{reflist|2}}
{{reflist|2}}


[[Category:Diseases involving the fasciae]]
[[Category:Diseases involving the fasciae]]
[[Category:Rheumatology]]
[[Category:Rheumatology]]
[[Category:Cardiology]]


[[fr:Syndrome de Sharp]]
[[fr:Syndrome de Sharp]]

Revision as of 18:21, 2 November 2012

WikiDoc Resources for Mixed connective tissue disease

Articles

Most recent articles on Mixed connective tissue disease

Most cited articles on Mixed connective tissue disease

Review articles on Mixed connective tissue disease

Articles on Mixed connective tissue disease in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Mixed connective tissue disease

Images of Mixed connective tissue disease

Photos of Mixed connective tissue disease

Podcasts & MP3s on Mixed connective tissue disease

Videos on Mixed connective tissue disease

Evidence Based Medicine

Cochrane Collaboration on Mixed connective tissue disease

Bandolier on Mixed connective tissue disease

TRIP on Mixed connective tissue disease

Clinical Trials

Ongoing Trials on Mixed connective tissue disease at Clinical Trials.gov

Trial results on Mixed connective tissue disease

Clinical Trials on Mixed connective tissue disease at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Mixed connective tissue disease

NICE Guidance on Mixed connective tissue disease

NHS PRODIGY Guidance

FDA on Mixed connective tissue disease

CDC on Mixed connective tissue disease

Books

Books on Mixed connective tissue disease

News

Mixed connective tissue disease in the news

Be alerted to news on Mixed connective tissue disease

News trends on Mixed connective tissue disease

Commentary

Blogs on Mixed connective tissue disease

Definitions

Definitions of Mixed connective tissue disease

Patient Resources / Community

Patient resources on Mixed connective tissue disease

Discussion groups on Mixed connective tissue disease

Patient Handouts on Mixed connective tissue disease

Directions to Hospitals Treating Mixed connective tissue disease

Risk calculators and risk factors for Mixed connective tissue disease

Healthcare Provider Resources

Symptoms of Mixed connective tissue disease

Causes & Risk Factors for Mixed connective tissue disease

Diagnostic studies for Mixed connective tissue disease

Treatment of Mixed connective tissue disease

Continuing Medical Education (CME)

CME Programs on Mixed connective tissue disease

International

Mixed connective tissue disease en Espanol

Mixed connective tissue disease en Francais

Business

Mixed connective tissue disease in the Marketplace

Patents on Mixed connective tissue disease

Experimental / Informatics

List of terms related to Mixed connective tissue disease

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor: Cafer Zorkun, M.D., Ph.D. [2]

Synonyms and keywords: MCTD; Mixed connective tissue disorder; Sharp's syndrome

Overview

Mixed connective tissue disease (MCTD) or Sharp's syndrome is a human autoimmune disease in which the immune system attacks the body. MCTD combines features of polymyositis, systemic lupus erythematosus, and systemic scleroderma and is thus considered an overlap syndrome. MCTD commonly causes joint pain/swelling, Raynaud phenomenon, muscle inflammation, and scarring of the skin of the hand. It does not typically cause kidney disease or seizures. Distinguishing laboratory characteristics are a positive, speckled anti-nuclear antibody and an anti-U1-RNP antibody.[1]

Pathophysiology

There are no specific histologic findings that aid in the diagnosis of Mixed Connective Tissue Disorder as a separate autoimmune disease. For example, nephritis in MCTD is usually indistinguishable from lupus nephritis.

Diagnosis

Anti–U1 small nuclear RNP positive

Mixed Connective Tissue Disorder Findings

A.Systemic lupus erythematosus–like findings

B.Progressive Systemic Sclerosis –like findings

  • Sclerodactyly
  • Pulmonary fibrosis, restrictive changes of the lung (forced vital capacity <80% of predicted), or reduced carbon monoxide diffusing capacity (<70% of predicted)
  • Hypomotility or dilatation of esophagus

C.Polymyositis-like findings

  • Muscle weakness
  • Elevated serum level of muscle enzymes (creatine kinase)
  • Myogenic pattern on electromyogram

MCTD is characterized by anti–U1 small nuclear RNP positivity.

Cardiac Involvement in MCTD

Cardiovascular abnormalities associated with mixed connective tissue disease are rare. Presence of any of the complications listed below indicates unfavorable prognosis;

References

  1. Venables PJ. Mixed connective tissue disease. Lupus. 2006;15(3):132-7. PMID 1663436
  2. Jang J J, Olin J W, Fuster V. A teenager with mixed connective tissue disease presenting with an acute coronary syndrome. Vascular Medicine; 2004, Vol. 9 Issue 1, 31-34

nl:Mixed connective tissue disease sv:Mixed Connective Tissue Disease

Template:WH Template:WikiDoc Sources